Lyrica CR Alternatives Compared
Lyrica CR (pregabalin) | Gabapentin | Lyrica (pregabalin) |
|
---|
Lyrica CR (pregabalin) | Gabapentin | Lyrica (pregabalin) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Neuropathic Pain, Diabetic Peripheral Neuropathy, Postherpetic Neuralgia. Lyrica CR may also be used for purposes not listed in this medication guide. |
Prescription only
Gabapentin is an anticonvulsant with pain-relieving effects that may be used to treat certain seizure disorders or relieve nerve pain. Common side effects include dizziness or drowsiness and it may... View more |
Prescription only
Lyrica can help relieve nerve pain and control seizures but it is likely to cause drowsiness. Prescribed for Neuropathic Pain, Neuralgia, Fibromyalgia, Diabetic Peripheral Neuropathy, Postherpetic... View more |
Related suggestions Neuropathic Pain
Diabetic Peripheral Neuropathy
|
|||||||||||||||||||||||
More about Lyrica CR (pregabalin) | More about Gabapentin | More about Lyrica (pregabalin) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Lyrica CR has an average rating of 7.1 out of 10 from a total of 7 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 29% reported a negative effect. |
Gabapentin has an average rating of 7.1 out of 10 from a total of 2588 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 21% reported a negative effect. |
Lyrica has an average rating of 6.4 out of 10 from a total of 931 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Lyrica CR side effects |
View all Gabapentin side effects |
View all Lyrica side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Lyrica CR prices |
View all Gabapentin prices |
View all Lyrica prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other pregabalin brands include: Lyrica | Fanatrex, Gabarone, Gralise, Neurontin | Other pregabalin brands include: Lyrica CR | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
6.3 hours |
6 hours |
6.3 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 287 drugs are known to interact with Lyrica CR:
|
A total of 271 drugs are known to interact with Gabapentin:
|
A total of 287 drugs are known to interact with Lyrica:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
October 11, 2017 |
December 30, 1993 |
December 30, 2004 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.